Statistics

Total Visits

Views
Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies21

Select a period of time:

Number of views in the range

Views
Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies6

Views

Views
September 20240
October 20240
November 20240
December 20240
January 20250
February 20252
March 20254
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore4
Germany1
United States1
 

Top cities views

Views